High Cytokines Predicted Weaker Placebo Response in Cancer Symptom Trial
A 2026 exploratory analysis of the ABCD cancer dyspnea trial found that higher baseline cytokines predicted less placebo symptom improvement than lower baseline cytokines across 33 of 40 cyt…
Read article